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Abstract 
A gene-level targeted enrichment method for direct detection of epigenetic modifications is described. The 
approach is demonstrated on the CGG-repeat region of the FMR1 gene, for which large repeat expansions, 
hitherto refractory to sequencing, are known to cause fragile X syndrome. In addition to achieving a single-locus 
enrichment of nearly 700,000-fold, the elimination of all amplification steps removes PCR-induced bias in the 
repeat count and preserves the native epigenetic modifications of the DNA. In conjunction with the single-
molecule real-time sequencing approach, this enrichment method enables direct readout of the methylation 
status and the CGG repeat number of the FMR1 allele(s) for a clonally-derived cell line. The current method 
avoids potential biases introduced through chemical modification and/or amplification methods for indirect 
detection of CpG methylation events.  
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Introduction 
The inability to sequence microsatellite DNA expansions associated with a broad range of clinical disorders 
impedes the characterization of these loci and hampers epigenetic mapping within many of these regions 
(Kieleczawa 2006; Mirkin 2007; Walker 2007; Deaton and Bird 2011; Marmolino 2011; Udd and Krahe 2012; 
Evans-Galea, Hannan et al. 2013; Nelson, Orr et al. 2013). Therefore, development of a targeted enrichment 
methodology is essential to the epigenetics study of these regions. At present, several different enrichment 
methods have been employed for such investigations; however, none of them can be used for direct genomic 
DNA-level epigenetic analysis. Polymerase chain reaction (PCR) can routinely target regions of the genome up 
to ~10kb in length, but suffers the dual disadvantages of being an error-prone replication method, particularly 
for amplification of microsatellite sequence (Loomis, Eid et al. 2013) and regions of extreme GC content 
(Mutter and Boynton 1995; Kieleczawa 2006), and of destroying information about the methylation state of the 
sequence. Methylation information can now be read directly from genomic DNA through single molecule real-
time (SMRT) DNA sequencing (Flusberg, Webster et al. 2010), however the SMRT methodology does not 
intrinsically focus sequencing from a sample embodying the whole genome onto a single locus. 
Hybridization capture methods (Mamanova, Coffey et al. 2010; Teer, Bonnycastle et al. 2010) have been 
widely used in exome sequencing (Choi, Scholl et al. 2009), resulting in extensive enrichment and focused 
sequencing of exomes. However, such methods do not presently yield fragments long enough to exploit the 
long-read technologies now available for detection of structural variations and phasing of mutations. Ligation-
based target-enrichment methods have been applied to good effect on panels of genes, but because these 
methods rely on circularization of DNA (Dahl, Gullberg et al. 2005), limitations on the kinetics of ligation-
based circle closure limit the applicability of these methods to fragments well below a kilobase in length. In 
addition, the available implementations of these methods still rely on PCR to produce an amount of targeted 
material suitable for sequencing which destroys the epigenetic modifications. 
Electrophoretic techniques, such as synchronous coefficient of drag alteration (SCODA) that are suitable for 
processing large amounts of input material are being adapted to the task of target enrichment (So, Pel et al. 
2010), but these methods are so far limited to short fragments and have the disadvantage of unlinking the sense 
and antisense strands of duplex DNA, confounding the analysis of hemi-methylation (Murray, Clark et al. 2012). 
To circumvent the limitations described above, we present a method for enriching a specific genomic locus that 
does not rely on amplification, thus preserving the methylation information contained in the genomic fragments, 
as well as inter-strand linkage information. 
As a specific example of the applicability of our method, we have focused on the fragile X (FMR1) locus; 
where CGG-repeat expansions and epigenetic silencing give rise to fragile X syndrome (FXS), the leading 
heritable form of intellectual disability and leading single-gene form of autism (Hagerman, Hoem et al. 2010), 
and the fragile X-associated disorders, including the neurodegenerative disorder, fragile X-associated 
tremor/ataxia syndrome (FXTAS) (Hagerman 2013). In the United States, the carrier frequency for expanded-
repeat alleles is approximately 0.5%, and a much larger fraction (~3%) is indicated for testing based on 
increased risk (Hagerman and Hagerman 2013). There is a complex relationship between the size of the CGG-
repeat and the nature of the clinical phenotype, with distinct CGG-repeat ranges corresponding to qualitatively 
distinct groups of patient outcomes (Gallagher and Hallahan 2012; Hagerman and Hagerman 2013). Further 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
complicating the molecular analysis of the FMR1 locus is the fact that its methylation state is an important 
modifier of the phenotypic impact of the repeat expansion on the affected individual. 
To date, no method has been capable of direct analysis (i.e., avoiding bisulfite modification, cloning, and/or 
PCR amplification) of the patterns and extent of methylation across the promoter region of the FMR1 locus, 
particularly within the CGG-repeat. Recently, it was demonstrated that single-molecule, real-time (SMRT) 
sequencing is capable of sequencing the CGG-repeat region, even for highly expanded CGG-repeat alleles in the 
full mutation range (>200 CGG repeats) (Loomis, Eid et al. 2013), despite its highly repetitive structure and 
100% GC content. However, the locus was isolated using either cloning or PCR to provide the necessary 
enrichment, resulting in loss of the methylation status of the gene. In the current work, we report that a 
combination of single-locus (FMR1) enrichment/capture, coupled with the unique capability of SMRT 
sequencing to follow the kinetics of nucleotide incorporation, facilitates the direct mapping of methylated 
cytosines at the level of genomic DNA. 
Materials and Methods 
Restriction enzyme DNA fragmentation 
Genomic DNA from the lymphoblastoid cell line, AG09391 (“AG”; NIA Cell Repository) from a normal 
female (16, 29 CGG-repeat alleles) (Tassone, Hagerman et al. 2000; Primerano, Tassone et al. 2002; Arocena, 
Iwahashi et al. 2005) was extracted and purified to remove traces of RNA, ssDNA and contaminants that 
interfere with restriction enzyme (RE) and ligase activity. The gDNA was digested to completion using type IIS 
restriction enzyme, Bsm AI or Bco DI (isoschizomer of Bsm AI) (NEB), in the optimal buffer. For preparation 
of each single-locus capture library, 18 - 20 µg gDNA was digested at 55oC for 16 hrs at a final concentration of 
20 µg/mL. Five units of Bsm AI were used per microgram of gDNA. The efficiency of RE digestion was 
verified by PCR using primers across the RE sites. Bsm AI has 5-base recognition sequences, GTCTC and 
GAGAC, so the average Bsm AI–digested fragment is 512 bp (= 45/2) assuming perfectly random sequence. For 
example, a 6.4 Gb genome of a typical female would yield ~12.5 x 106 fragments (= 6.406 x 109 / (45/2)). Each 
end of the Bsm AI-fragments has a 4-base overhang determined only by the local sequence at the site of 
cleavage resulting in 256 (= 44) different 4-base combinations. Therefore, a specific Bsm AI-fragment with the 
same two ends would be found only once in every 65,536 fragments (44x44).  
Adapter ligation 
Based on the estimated 12.5 x 106 fragments created by Bsm AI, and an added specificity of 256-fold for each 
4-base adapter-end, the ligation step using 2 sequence-specific adapters is expected to generate 764 fragments 
with adapters at both ends, ~200,000 fragments with only one adapter, and > 106 fragments with no adapters 
(Table S1). Among the 764 molecules that should have adapters at both ends to form cyclized SMRTbells, 573 
(75%) have at least one Bsm AI recognition site inside the fragment. This is because each fragment has either 0 
(~25%), 1 (~50%) or 2 (~25%) Bsm AI recognition sites, which can be recut by Bsm AI. Thus, Bsm AI was 
allowed to remain active during and after the ligation step to destroy these non-target molecules. For these 
reasons, the Bsm AI digestion was used directly for the adapter ligation reaction. Two specific hairpin adapters 
were designed with a 5’-CTGT overhang and a 5’-AATG overhang, respectively, such that the 5’-end of each 
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adapter has a single-strand overhang that is complementary to the targeted 1.1 kb FMR1 fragment. The 
sequences of adapter A and adapter B were 5’-
pCTGTATCTCTCTCTTTTGCTCCTCCTCCTCCGTTGATTGTTGTTGGAGAGAGAT and 5’-
pAATGATCTCTCTCTTTTGCTCCTCCTCCTCCGTTGATTGTTGTTGGAGAGAGAT, respectively. 
A stoichiometric excess of the hairpin adapters is required to minimize self-ligation of the fragments. For 
high-fidelity sticky-end ligation, E. coli ligase (NEB) was found to be superior to T4 DNA ligase, as the latter 
was much more permissive of the ligation of non-complementary ends. Thus 200 nM of each adapter was 
incubated with 20 µg/ml of Bsm AI-digested DNA fragments (50 nM, based on an estimated average size of 
512bp for the DNA fragments) in 1x E. coli ligase buffer for 30 minutes at 37oC. The ligation reaction was then 
started by adding E. coli ligase (0.15 U/µl E. coli ligase; ~10 U ligase per µg DNA fragments) followed by an 
additional incubation at either RT (~22oC) or 37oC (comparison in Table 1) for ~16 hours.  
DNA size selection 
Following the ligation step, 0.35x and 0.65x volume of Ampure beads were used for DNA clean-up and size 
selection.  Since the targeted FMR1 fragment is about 1.1 kb, DNA fragments between 0.5 kb and 3 kb were 
selected and purified from the ligation reaction. First, 0.35x volume of washed AMPure beads (PacBio) was 
added into the ligation products to remove DNA fragments larger than 3 kb. After mixing at 500 rpm using a 
vortex mixer for 10 minutes, the beads were separated on the wall of the tube using a magnetic stand. The 
supernatant, with DNA fragments less than ~3 kbp, was transferred to a new tube. An additional 0.30x volume 
of AMPure beads was added into the reserved supernatant such that the final bead volume is 0.65x of the 
original sample. After mixing at 500 rpm for 10 minutes, DNA fragments larger than 500 bp were attracted to 
the magnetic beads. The DNA fragments were cleaned further by two 75% ethanol washes, and then eluted from 
beads using 10 mM Tris-HCl, pH 8.0 (or EB buffer from Qiagen). 
Digestion of non-target DNA fragments 
DNA fragments with 0 or 1 adapter (non-cyclized) are good substrates for exonuclease III (NEB) and 
Exonuclease VII (USB), whereas the fully-cyclized fragments with two adapters should be resistant to the 
exonucleases.  When all non-cyclized fragments have been eliminated, the quantity of double-stranded DNA 
(dsDNA) should be ~65,000-fold (accounting for the two-adapter fragments that can be recut by Bsm AI) lower 
than the starting material (e.g., ~300 pg DNA from 20 ug of starting gDNA). In practice, the Exo-treatment is 
stopped when the remaining quantity of dsDNA is ~50 ng, in order to maintain a sufficient amount of gDNA to 
carry out downstream steps. 
In the exonuclease treatment reaction, 1.7 unit/µl Exo III and 0.1 unit/µl Exo VII were used for 100 ng/µl 
DNA in 1x NEBuffer 3.  The reaction was incubated for 1-2 hr at 37oC and a Qubit fluorometer was used to 
monitor the concentration of dsDNA. The reaction was stopped when total dsDNA was reduced to ~45-50 ng. 
Remaining DNA was purified by using 0.65x volume of Ampure beads.  
T7 Exonuclease, Exonuclease I and Rec Jf (NEB) were found to have lower endonuclease activity compared 
to Exo III and Exo VII. These exonucleases were used for the male gDNA samples (samples with expanded 
CGG repeat allele). A combination of 10 units of T7 Exo, 10 units of Exo I and 10 units of Rec Jf per µg DNA 
were used; each sample had a concentration of 100 ng/µl DNA in 1x NEBuffer 4. A carrier supercoiled plasmid 
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(pUC18 or pBR322), 500 ng, was added to each DNA sample before the Exo-digestion to aid in the recovery of 
the enriched templates during Ampure purification. The reaction was incubated for 4 hrs at 37oC. The extent of 
exonuclease treatment was evaluated by measuring the amount of remaining dsDNA by Qubit, where the 
reaction was considered complete as it approached the amount of plasmid carrier added (500 ng). The enriched 
templates and plasmid DNA were purified from the reaction by using 0.65x volume of Ampure beads. 
Annealing primer to the enriched template with ligated adapters 
A sequencing primer that has reversed and complementary sequence to the loop region of the adapter is used for 
polymerase binding and DNA synthesis. The primer sequence is: 5’-CAACGGAGGAGGAGGAGC-3’ (IDT, 
Iowa City, Iowa). The ratio of primer concentration to template concentration is approximately 10, such that all 
templates with hairpin adapters can have 2 primers per template. Hybridization of the primer to the template was 
carried out in 1x Primer buffer (10 mM Tris-OAc, pH 8, 12 mM KOAc) using a thermocycler setting at 70oC for 
5 minutes, and temperature decreases by 0.1oC per second until it reaches 22oC. The primer-annealed templates 
can be stored at 4oC. 
Formation of polymerase-template complexes 
To form the polymerase-template complex for primer extension and final sequencing, C2 or P5-polymerase 
(PacBio) was bound to the primer-annealed templates. In the reaction, 30 nM of polymerase was incubated with 
0.5 ng/µl primer-annealed templates (0.7 - 10 nM) in buffer containing 10 mM Tris-OAc, pH 8.0, 10 mM KOAc, 
0.05% Tween-20, 40 mM DTT, 0.4 mM Strontium acetate, 1 µM dNTP at 30oC for at least 3 hrs.   
Capture-hook hybrid selection method  
To further enrich the targeted region, a capture-hook hybridization selection method (developed at PacBio as the 
SMRThookTM method) was performed. 0.1x volume of 5 mM Magnesium acetate was added to the polymerase-
template complex for 30 min incubation at RT, thereby extending the annealed primers by ~30-50 bases to form 
open single-stranded DNA sections in the stem of the SMRTbell template. The extension reaction was stopped 
by adding 0.07x volume of 30 mM EDTA to the mixture (final 2 mM EDTA). After incubation for 5 minutes, a 
0.1x volume of 50 mM strontium acetate (final concentration of 5 mM Sr2+) was added to stabilize the “open 
complex”. The single-stranded DNA in the “open complex” is specific for each template. A capture-hook DNA 
oligonucleotide is designed to have an 18 nucleotide probe sequence specific to the targeted FMR1 open 
complex and a 23 nucleotide oligo-dA tail, allowing hybridization with (dT)25 oligos derivatized on the surface 
of magnetic beads in the following procedure. The sequence of FMR1capture-hook oligo is: 5’-
CTAGCGCCTATCGAAATGGTCAAAAAAAAAAAAAAAAAAAAAAA-3’. 
A 0.1x volume of 2 µM capture-hook oligo was added to the “opened complex” solution such that the 
capture-hook concentration is about 200 nM (>200-fold excess of the targets). Since the concentration of salt is 
low in the “opened complex” sample (<10 mM KOAc), a 0.1x volume of bead wash buffer (BWB; 400 mM 
KOAc; PacBio) is added to the sample to allow efficient hybridization of the capture-hook oligo to the opened 
complexes and to the (dT)25 oligos on beads. The hybridization reaction is carried out at RT using a rotating 
platform for 2 hours. Then the opened complexes with the annealed probe oligo were captured on magnetic 
beads through the interaction of (dA)23 on the probe oligo and the (dT)25 oligos which are covalently coupled to 
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the beads. For each sample, 50 µl of magnetic beads- (dT)25 oligos was washed with 50 µl aliquots of BWB and 
then bead binding buffer (BBB) from PacBio. Before binding to the complexes, the BBB was removed from 
solid beads using the magnetic stand. The sample of open complexes hybridized to the probe oligo was applied 
to the solid beads, and were mixed well by gently pipetting up and down. The hybridization reaction is carried 
out at RT for 1 hr using a rotating platform for efficient annealing of the capture-hook to the (dT)25 beads. 
Complexes that do not have the annealed capture-hook oligo are washed away from magnetic beads using the 
reagents and protocol described in the Bead-binding kit (PacBio).  
The retained opened complexes on the magnetic beads, with the highly enriched targeted templates, are used 
for loading the active Pol-template complexes into ZMWs on a RS cell for sequencing on the PacBio RS II 
system. 
Sequencing and Analysis on the PacBio RS II system 
SMRT sequencing was carried out on the PacBio RS (Pacific Biosciences, Menlo Park, CA, USA) using 
standard C2/C2 chemistry for bead-loading of SMRTbell libraries. Sequencing reads were processed and 
mapped to the respective reference sequences using the BLASR mapper and the Pacific Biosciences' SMRT 
Analysis pipeline using the standard mapping protocol.   
The standard open source analysis software available for SMRT Sequencing now contains a full suite of 
kinetic analysis tools. This includes calculation and visualization of both the raw and ratio versions of the IPD in 
a strand aware manner (Figures 4, 5 & 6). Analysis and plotting customization utilized the available R tools. 
The determination of the CGG region repeat count follows the method discussed in Loomis et al. (Loomis, 
Eid et al. 2013). Briefly, the circular consensus sequence (CCS) FASTQ files are aligned to both flanking 
regions independently. It is important to note that these reads are arrived at through a single molecule 
sequencing consensus algorithm that accounts for the expected error of the chemistry used (Chin, Alexander et 
al. 2013). This demarcates the repeat region borders and provides a direct assessment of the single molecule 
read quality. A cut-off of 5% error in the alignment to either flank, as well as a requirement that the strand 
direction matches, is imposed. In this filtered subset, C to G and G to C transitions are tabulated to report on the 
repeat region count. 
The alignment justified raw IPD measurements are directly available from the cmp.h5 files produced after 
aligning the raw data to an expected reference using SMRT Portal. The reference can be arrived at in a de novo 
manner by using the RS_Long_Amplicon_Analysis.1 protocol. The mean IPD per position is then divided the 
value obtained from the unmodified case-control to obtain the IPD ratio measurements that remove the sequence 
context effect. 
Generation and sequencing of unmethylated control templates  
For comparison of the IPD ratio of native DNA, unmethylated control DNAs containing 20 CGG repeats and 30 
CGG repeats as well as some flank sequence were made into template for sequencing.  
The 20 CGG fragment was generated by annealing two synthesized oligos that have reverse and 
complementary sequence. The sequences of these two oligos are:5’-
pCCACTGCTGCAGCACGGCGGCGGCGGCGGCGGCGGCGGCGGCGGAGGCGGCGGCGGCGGCGGC
GGCGGCGGCGGCTGGGCCTC; 5’- 
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pGCTGGAGGCCCAGCCGCCGCCGCCGCCGCCGCCGCCGCCGCCTCCGCCGCCGCCGCCGCCGCCGC
CGCCGCCGTGCTGCAGCA. 20 µM of each oligo was annealed in 10 mM Tris.HCl, pH 8, 25 mM NaCl, by 
heating at 80oC for 5 min and cooling to RT over 30 min to form double strand DNA (dsDNA) having 5’-
pCCAC and 5’-pGCTG overhangs. The annealed 20 CGG fragments were then ligated to two adapters having 
complementary overhang sequence to both ends. The adapter sequences are: 5’-
pGTGGCATCTCTCTCTTTTGCTCCTCCTCCTCCGTTGATTGTTGTTGGAGAGAGATG; 5’-
pCAGCCATCTCTCTCTTTTGCTCCTCCTCCTCCGTTGATTGTTGTTGGAGAGAGATG. A 100 µl ligation 
reaction, with 4 µM each of these two hairpin adapters, 2 µM of hybridized oligos, and 0.15 U/µl E. coli ligase 
(NEB) in 1x E.coli ligase buffer), was incubated at 37oC overnight. After inactivation of ligase at 65oC for 20 
min, 10 µl of the ligation mixture was diluted to 50 µl in 1x NE buffer 1. 0.34 U/µl Exo III and 0.02 U/µl Exo 
VII were used to degrade failed ligation products at 37oC for 1 hr. 2x volume of Ampure beads were used to 
purify the 20 CGG SMRTbell templates.  
The 30 CGG fragment was acquired by PCR-amplification of a 572bp fragment encompassing the CGG 
repeat (30 CGG) and adjacent 5’UTR flanking sequence from 30 CGG cloned pBR322 plasmid.  The PCR 
product was purified and ligated with T-overhang adapters. The adapter sequence is 
5’-pTCTCTCTCTTTTCCTCCTCCTCCGTTGTTGTTGTTGAGAGAGAT. The ligation reaction was 
performed using the standard SMRT library preparation protocol (DNA Template Prep Kit 2.0, PacBio). Both of 
the unmethylated 20 CGG and 30 CGG templates were then sequenced using the PacBio C2 chemistry. 
Generation and sequencing of in vitro methylated control templates by Sss I 
The 20 CGG SMRTbell template sample, and the 30 CGG sample cut from the 30 CGG cloned plasmid, were 
both treated with 8-16 unit methyltransferase Sss I (NEB) per 1 μg DNA overnight at 37oC. After stopping the 
reaction by heat at 65oC for 20 minutes, methylated DNA was purified by Ampure beads. Methyl-sensitive 
restriction enzyme Aci I (NEB) was used to remove those incompletely methylated fragments from the Sss I 
treated pool. The efficiency of the methylation reaction was verified by following bisulfite sequencing. Then the 
methylated 30 CGG fragment was ligated with adapters having Pst I overhang by standard SMRT library 
preparation protocol (DNA Template Prep Kit 2.0, PacBio). The methylated 20 CGG SMRTbell templates and 
30 CGG SMRTbell templates were then sequenced using PacBio C2 chemistry. 
Results 
Targeted Enrichment 
We developed an enrichment method capable of targeting specific loci from purified native genomic dsDNA 
that takes advantage of the unique digestion properties of type-IIS restriction endonucleases (RE) (Figure 1). 
Because the type IIS enzymes cut at a specific distance outside of their recognition sequence, cleavage yields 
DNA fragments with single-stranded overhang sequence determined only by the local context at the site of 
cleavage. In the case of targeted enrichment, the overhang sequences are specified by the sequence at the locus 
of interest, thus allowing for the design of two independent hairpin adapters (“A” and “B” in Figure 1) to 
specifically ligate on the ends to form a circular SMRTbell template that is resistant to exonuclease digestion. 
For four nucleotide overhangs, the specific overhang sequences at each end are expected to provide an 
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additional 256-fold (= 44) specificity or 65,536-fold (= 44 x 44) specificity for a retained DNA fragment. 
Ligation of the locus-specific adapters to the digested genomic DNA, followed by exonuclease digestion of the 
unligated material, enriches the SMRTbell fraction from genomic DNA with zero or only one ligated adapter 
(Figure 1). Theoretical numbers for the target and non-target fragments are presented in Table S1 and are based 
on ideal conditions for the following steps: gDNA digestion by RE (Bsm AI), ligation of adapters, and 
exonuclease digestion. The true number is expected to be lower due to a number of potential factors: reduced 
RE efficiency due to methylation; contaminants in the DNA sample (e.g. ssDNA, RNA); mutation of the DNA, 
especially at the ends of the targeted fragment; and the specificity and extent of optimization of the enzymes 
(RE, ligase, exonuclease) themselves.  
To further enrich the locus of interest, we included a sequence-specific “capture-hook” method in which the 
annealed primers are extended to form open single-stranded DNA sections (Figure 1) in the stem of the 
SMRTbell template. This exposed single-stranded portion allows for targeted capture using an oligo containing 
15-25 bases of locus-specific complementary sequence as well as a (dA)23 tail to link the complex to (dT)25-
magnetic beads. Once captured on magnetic beads, the sample can be loaded directly onto the SMRTcell for 
sequencing. 
FMR1 Enrichment Example 
For the current application, genomic DNA was isolated and purified from an Epstein-Barr virus (EBV)-
transformed lymphoblastoid line (designated AG) derived from a normal female (~16 and ~29 CGG repeats 
were estimated previously by polyacrylamide gel electrophoresis) (Primerano, Tassone et al. 2002). For 
preparation of each single locus capture library, 18.3 µg of genomic DNA (corresponding to 6.75 pg of the 
~1.1kbp target locus) was digested using the type IIS enzyme, Bsm AI (GTCTCN^NNNN), which leaves a 4-
base overhang specified by the sequence context of the cut site. The 1.1 kb fragment of interest contains the 
CGG repeat site with an upstream 5’-ACAG overhang and a downstream 5’-CATT overhang. The resulting 
fragment pool is then circularized by ligation to specific adapters with overhang sequences that are 
complementary to the overhangs created by Bsm AI, thus yielding increased FMR1 specificity (5’-CTGT on the 
upstream “A” adapter and 5’-AATG on the downstream “B” adapter). Note that, except for the 4-base 
overhangs, these sequences are similar to the standard SMRTbell preparation adapters (Travers, Chin et al. 
2010). High-fidelity E. coli ligase (NEB) was used under specific conditions to reduce the fraction of off-target 
ligation (Materials and Methods).   
When, as in this case, the target fragment does not embody the recognition sequence, the same restriction 
enzyme can be allowed to remain active during and after the ligation, so that the non-target fragments that have 
ligated adapters at both ends but do contain a Bsm AI recognition motif will be cut open once again. Fragments 
with at least one open end were then digested using exonucleases III and VII. Circular fragments closed at both 
ends are resistant to exonuclease activity. To render the locus-specific probe available for hybridization, the 
SMRTbell templates are primed in the hairpin region and bound with sequencing polymerase (Pacific 
Biosciences, C2 chemistry), and then extended in a solution that contains dNTPs and Mg2+, as well as Sr2+ to 
slow the reaction. The priming reaction is quenched with EDTA and additional Sr2+ is added after exposure of 
~40 bases of single-stranded insert DNA at one end of the FMR1 fragment. After quenching, the resulting open-
complex comprising the partially strand-displaced fragment, extended primer and polymerase is annealed with 
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the specific bridging oligo at 30oC and this target specific complex is captured by oligo-dT-derivatized magnetic 
beads (“Magbeads”) as in the standard Magbead loading protocol. The retained complexes and the Magbeads 
were then applied to a SMRTcell and sequenced. This process was repeated with appropriate modifications for a 
number of control samples as well.  
Methylation-positive controls were prepared by performing an in vitro methylation of a synthetic 20 CGG 
repeat containing molecule, and plasmid-derived 30 CGG repeat containing species using Sss1 
methyltransferase. The level of methylation was confirmed using bisulfite sequencing (Table S2 and Figure S1). 
Sequencing and analysis 
The native targeted DNA sequencing run, from a sample using E. coli ligase at 37C (see Table 1), yielded 
2,968 reads that map to the human genome with non-mapping reads comprising mitochondrial sequences, 
adapter dimers and other contaminating DNA. Of the reads that map to human (human_g1k_v37 reference), 325 
of them (11%) were specific to the 1.1 kbp FMR1 fragment region representing ~692-fold coverage (average of 
2.1 sub-reads per molecule). A coverage map of the X-chromosome reveals a clear peak at the FMR1 locus, and 
a read-map of this region indicates that the vast majority of reads begin and end where expected (Figure 2). 
Without enrichment one read in roughly 6.26x106 (= (6.41x109 /512)/2) would be expected to map to this locus, 
therefore, an on-target rate of 11.0% (= 325/2,968) corresponds to an estimated enrichment factor of ~688,600 
(= fraction of FMR1 reads / fraction of FMR1 fragment in the RE digest = 0.11 x 6.26 x 106). The procedures 
were performed in duplicate with the exception of using different ligation temperatures, 37oC and 22oC; the 
number of targeted reads and specificity of enrichment were within approximately 20% due to better ligation 
fidelity at higher temperature for sticky end ligation. 
Sequences that mapped to the FMR1 region and which also possessed at least three subreads were selected 
for further analysis, as in (Loomis, Eid et al. 2013). The most likely consensus sequence is arrived at through an 
algorithm which combines the subreads by taking into account the expected error profile (Chin, Alexander et al. 
2013). To further minimize homopolymer slip, only the CG or GC transitions are counted in estimating the 
repeat length. The results are shown in Figure 3. There were two distinct populations of repeat lengths with 
modes at 20 and 30 repeats. This result represents a refinement of the earlier PCR-electrophoresis result. The 
standard deviations of the two clusters were 0.90 and 1.0 for the clusters at 20 and 30 repeats, respectively. The 
numbers of reads observed in each cluster (42 and 46, respectively) are consistent with a heterozygous female. 
Kinetic analysis for methylation 
The information provided by SMRT sequencing inherently includes the kinetics of each nucleotide 
incorporation, which has been shown to inform on the methylation status of DNA. Because the data are from 
unamplified gDNA, cytosine methylation remains intact and can thus be directly queried without bisulfite 
conversion or similar approach. The inter-pulse duration (the interval between the end of a sequencing pulse and 
beginning of the subsequent pulse - IPD) is perturbed by the presence of many chemical modifications of the 
template, and is also sensitive to the local sequence context  (Flusberg, Webster et al. 2010). Thus, a kinetic 
reference representing the expected kinetics for unmodified DNA is needed to distinguish sequence context 
effects from actual modifications. The usual in silico reference approach relies on training data which, at present, 
does not contain a sufficient sampling of this rare repeat motif. Accordingly, for the analysis of the current data, 
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an unmethylated sample with identical sequence was created using multiple displacement amplification 
(Hutchison, Smith et al. 2005) and sequenced under the same conditions. The upper row plots in Figure 4 depict 
a comparison of the observed mean IPD values with associated standard errors of nucleotide incorporation for 
the forward strand of the two alleles between the native genomic DNA (red bars) and the amplified (and thus 
unmethylated) reference sample (blue bars). The pattern of sequence-context dependent kinetic variation that is 
common between the two samples is clearly visible and, therefore, it is convenient to plot the ratio of the native 
to unmethylated IPDs (bottom row of Figure 4) which reveals methylation of the forward strand in the 20 CGG 
allele but not in the 30 CGG allele. All 4 enriched samples from the same female gDNA in Table I showed 
qualitatively similar patterns as the data shown in Figure 4. 
To confirm this finding, synthetic oligonucleotides reflecting the CGG repeat and flanking regions were 
prepared and used either unmodified or in-vitro-methylated (using Sss1 methyltransferase), as negative and 
positive controls, respectively. Figure 5 shows the IPD ratio plots for the positive control (top row), native DNA 
(middle row) and negative control (bottom row) for both forward and reverse strands and confirms that the 
forward strand of the 20 CGG allele is methylated and that the forward strand of the 30 CGG allele is not. The 
degree to which the forward strand of the 20 CGG repeat is methylated can be inferred from a direct comparison 
of the positive control to the native DNA (Figure S2). The values of the IPD ratios are largely within the 
standard error of the measurement in the CGG repeat sequence suggesting that the native DNA is very close to 
100% methylated. The same cannot be said regarding the reverse strand because the magnitude of the kinetic 
signal due to methylation is much smaller relative to the forward strand (see Figure 5 – Positive control for 
reverse strand). Therefore, from these data alone, it is not possible to determine if the reverse strand of either the 
native 20 CGG repeat or the native 30 CGG repeat is methylated even though it is likely that the reverse strand 
of the 20 CGG repeat is, in fact, methylated. However, because the standard error of the mean IPD values at 
each position is expected to decrease as a function of coverage, perhaps it would be possible to make a high 
certainty call with greater sequencing coverage than was obtained in this study. The difference in signal between 
the forward and reverse strands is likely due to the pronounced differences in kinetic response as a function of 
sequence context (Flusberg, Webster et al. 2010). 
It should be noted that despite a dense cluster of high IPD ratios confined within the repeat region (Figure 4 
and Figure 5), these observations are consistent with pervasive methylation across this portion of the forward 
strand of the native 20 CGG allele. The appearance of the cluster is likely due to a synergistic interaction 
between adjacent methylcytosines when they reside within the 10-12 base template-footprint of the sequencing 
polymerase, given the high density of CpGs within the FMR1 repeat region. Figure 6 shows the IPD ratio 
profile of the entire 1.1 kbp region for both alleles of the on-target fragment.  
Premutation repeat alleles 
Several gDNA preparations from male cell lines with normal and expanded CGG repeats were enriched in order 
to evaluate this technique on samples that more closely reflect premutation alleles. Some changes were made for 
these experiments due to the discovery of a slow, but significant, endonuclease activity present in Exo III and 
Exo VII. Instead, T7 Exo, Exo I, and RecJf were used, as this combination exhibited a greatly reduced rate of 
endonucleolytic cleavage (data not shown). At present, it is not clear if the endonuclease activity seen with Exo 
III/Exo VII is due to a contaminant or an inherent property of these enzymes. With this improvement, the 
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sequence-specific “capture-hook” step was not included for these samples, as the required level of enrichment 
was reached without additional purification. The enrichment factor was between roughly 17,000 and 33,000 and 
sufficient to estimate the length of the expansion (Table 2). The estimated CGG-repeat lengths were found to be 
in agreement with the known lengths for these gDNA samples determined by PCR-electrophoresis. As expected, 
IPD ratio analyses were consistent with the interpretation that the CGG repeats in these 4 samples are 
unmodified (Figure 7).  
Discussion 
Expansions of tandem-repeat DNA are associated with a broad range of clinical disorders, heavily weighted to 
neurodevelopmental and neurodegenerative syndromes [e.g., fragile X syndrome (CGG) (Verkerk, Pieretti et al. 
1991); Huntington disease and the spinocerebellar ataxias 1,2,3,6,7,12 (CAG) (Walker 2007); myotonic 
dystrophy (CTG) (Udd and Krahe 2012); Friedreich’s ataxia (GAA) (Marmolino 2011)]. However, most of the 
current sequencing technologies are not capable of sequencing long runs of tandem repeats, due to the absence 
of unique-sequence “landmarks” that would otherwise permit sequence tiling.   
Given the high prevalence of FMR1 expanded alleles in the general population (approximately 0.5% carrier 
frequency in the United States), and the availability of promising new targeted treatments, there is an urgent 
need for rapid and cost-effective detection of CGG-expanded alleles in early childhood. As SMRT sequencing 
provides the high throughput capability needed to sequence hundreds of clinical samples in tandem, this single-
locus sequencing technology could lead to more accurate, less expensive, and higher-throughput means for 
screening expanded alleles. 
The single-locus capture method presented here is, in theory, applicable to a broad range of repeat-expansion 
disorders, as well as to the study of many other forms of tandem-repeat DNA where the distinguishing feature is 
the lack of the complex/unique sequence milestones. Moreover, our single-locus capture methodology should 
permit enrichment of any locus in the genome; thus, it is broadly applicable to sequencing of any locus, 
especially those that are refractory to accurate PCR or sequencing due to either size or GC content.  
A rapidly increasing number of epigenetic modifications have been found to play important roles during 
development and disease involved pathogenesis, including mCG, mCH (non CpG), hmC, fmC, caC and 8-oxo-
G (Taddei, Hayakawa et al. 1997; Maga, Villani et al. 2007; Fu and He 2012; Lister, Mukamel et al. 2013; Shen, 
Wu et al. 2013; Shen and Zhang 2013; Song and He 2013; Song, Szulwach et al. 2013). Epigenetic studies of 
these modifications still mostly rely on chemical treatment of genomic DNA followed by PCR-based 
amplification, which often yields biased results, due to preferential utilization of primers targeting bisulfite-
converted (or unconverted) DNA sequence and/or to selective reamplification of specific sequences formed 
during the first few rounds of PCR. Thus, a second specific advantage of our approach is that it enables one to 
study directly the patterns of modifications of genomic DNA, without having to chemically modify and amplify 
the DNA; an approach that has broad applicability not only to microsatellite sequencing, but also for direct 
characterization of genome-level base modifications through the kinetic sequencing capability of SMRT 
sequencing. Finally, as an intrinsically single-molecule approach SMRT sequencing should provide the means 
for examining mosaicism of allele size and modification, which are not readily accessible by other methods. 
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Table and Figure Legends 
Table 1. Enrichment Efficiency Depends on Ligation Conditions. 
Table 2. Enrichment of Normal and Premutation Alleles from Male gDNA. 
Figure 1. A schematic of the amplification-free enrichment approach. Purified, unsheared genomic DNA is 
digested with specific type-IIS restriction enzymes (RE) selected to produce cuts on both ends of the desired 
target region. Ligation to hairpin adapters with complementary overhangs yields closed circular (SMRTbell) 
DNA, which is refractory to subsequent digestion with exonuclease types III and VII. Fully formed off-target 
SMRTbell templates can be cut through the use of additional REs (chosen to not cut within the desired target 
sequence) or the same RE (since many off target molecules will still maintain the recognition site within the 
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SMRTbell). The enriched region of interest is primer-annealed, and polymerase is added and allowed to extend 
by ~40 nucleotide into the locus-specific DNA region, thus allowing for further selectivity based on annealing 
of a locus-specific SMRThook. 
Figure 2. A) Coverage map of the entire X-chromosome showing the main localization at the FMR1 region with 
692x coverage (red bar) with one minor off-target site that contains both Bsm AI cleavage sites and a poly(A) 
tract that is non-specifically bound to the beads. B) Zoom in on the area immediately surrounding the FMR1 
region, demonstrating the precise restriction site ends of the reads. 
Figure 3. Histogram of the CGG repeat length from circular consensus sequence (CCS) reads. This shows that 
there are two populations that represent the two alleles present in this clonal female lymphoblast cell line.  
Figure 4. Direct observation of X-inactivation in which the 20 CGG allele is highly methylated whereas the 30 
CGG allele shows no evidence of methylation. The top row contains the raw mean IPD values of both the native 
(red bars) and amplified (blue bars) samples with standard error bars. The bottom row is the ratio between the 
native and amplified samples at each template position minus one to highlight kinetic differences from an 
unmodified position. The standard error of the mean IPD values were propagated in the calculation of the ratio 
and shown as error bars in the plot. 
Figure 5. Comparison of native samples (middle row) to negative (bottom row) and positive (top row) controls 
for 20 and 30 CGG repeat lengths. The forward strand of the 20 CGG allele mirrors the positive control, while 
the 30 CGG allele does not. The standard error of the mean IPD values were propagated in the calculation of the 
ratio and shown as error bars in the plot. 
Figure 6. View of the IPD ratio parameter over the 1.1 kb FMR1 gene region that was enriched showing that 
areas outside the CGG repeat section (below the red ‘CGG’ boxes), of the 20 CGG allele, also appear to be 
modified on both strands. The promoter region is indicated by the blue boxes and the TSS arrows delineate the 
transcription start site locations. 
Figure 7. IPD ratio analyses for the CGG repeat regions in 4 male samples.  Comparison of IPD ratio over the 
same enriched FMR1 gene region from 4 male gDNA samples indicates that the CGG repeats in these 4 samples 
are unmodified. 
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Table 1. 
Sample 
Total post-filtered 
Reads  
Mapped Reads 
to Human 
Mapped 
Reads to 
FMR1 
FMR1 Specificity Enrichment*  
E. coli ligase @ 37C 4,517 2,968 325 0.1095 685,198 
E. coli ligase @ 22C 4,523 3,350 278 0.0830 519,142 
T4 ligase @ 37C 10,807 8,694 222 0.0255 159,751 
T4 ligase @ 22C 14,378 12,330 246 0.0200 124,812 
T4 ligase @16C 
(no active Bsm AI during 
ligation) 
46,675 42,707 46 0.001077 6,738 
 
 
(*) Fold of Enrichment = Fraction of FMR1 read / Fraction of FMR1 fragment after Bsm AI digest = Fraction of FMR1 read / 
[2/(6.406x10
9
/512)] using genomic DNA from the lymphoblastoid cell line, AG09391 from a normal female (16, 29 CGG-repeat 
alleles). 
 
(Bsm AI-digested human female diploid (6.406x10
9 
bp) : 512bp average fragment size)  
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Table 2. 
Sample 
Total post-filtered 
Reads  
Mapped Reads 
to Human 
Mapped 
Reads to 
FMR1 
FMR1 Specificity Enrichment*  Repeat Length 
Library 1019-09 /26** 32909 26916 43 0.00160 20253 28.5 + 0.7 
Library TS-107-12/71 32101 25603 53 0.00207 26203 69.3 + 2.4 
Library 1066-09-RW/97 26723 22199 58 0.00261 33038 94.9 + 7.8 
Library TS-109-12/128 20853 16037 22 0.00137 17342 118.5 + 7.6 
 
 (**) line designation / CGG-repeat size 
(*) For human male diploid, the fraction of Bsm AI-fragments with an FMR1 locus is ~7.9 x 10
-8
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Figure 7. IPD ratio analyses for the CGG 
repeat regions in 4 male samples.
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